MOH Seizes Retatrutide Weight-Loss Drugs Worth RM341,000
Published
The Ministry of Health (MOH) has seized retatrutide drugs worth more than RM300,000. This information was presented in Parliament. Retatrutide is a drug related to the GLP-1 group and is often associated with weight loss. The total value of the drugs seized is estimated at RM341,000.
According to the report, the seizures were made over the period from 2025 to September. These drugs were seized because they were found to be sold or distributed illegally. Cases like these show that unregistered drugs can still be found on the market.
GLP-1 drugs are used to treat type 2 diabetes and help reduce body weight under the supervision of a doctor. Retatrutide, meanwhile, is still at the clinical trial stage and has not been approved for widespread sale in Malaysia. Therefore, using it without medical advice may endanger health.
Consumers are advised to be careful and consult a doctor before using any weight-loss medication. The public should also avoid buying medicines from untrustworthy sources, especially on the internet.
Sources: The Star
More Malaysia news
- Malaysian Stock Market Opens Higher After US Tech Stocks Recover
- Analysts: Malaysia's Tech Sector Faces Sentiment Decline, Not Earnings Impact
- Skilled Workforce Essential for Malaysia's Digital Transformation
- Malaysia Outlines Plans to Strengthen Digital Security and Improve Internet Connectivity
- Malaysia Targets One Million Affordable Homes Through Modular Construction Technology
- Two New Political Parties Emerge Amid Political Divisions in Malaysia
- Sabah PH Chairman Urges Parties Not to Use Religion as a Political Weapon
- Malaysia Wants Smoother Medical Claims Process